Related by context. All words. (Click for frequent words.) 69 novel peptide 67 anticancer therapeutics 65 humanized monoclonal 65 antisense inhibitor 65 antisense inhibitors 64 Squalamine 64 AKT inhibitor 64 antimitotic 64 Locked Nucleic Acid 64 JAK inhibitors 64 romazarit 64 JAK2 inhibitors 64 INS# [001] 64 HIV integrase inhibitors 63 monoclonal antibody MAb 63 SAR# [002] 63 ENMD # 63 proteasome inhibitors 63 delipidation 63 polycythemia vera PV 63 monoclonal antibody mAb 63 humanized antibody 63 therapeutic monoclonal antibody 63 M2 subunit 63 multi kinase inhibitor 63 Cyclosert TM 63 humanized monoclonal antibodies 63 adrenergic regulation 63 microtubule inhibitor 63 Nanobody 63 GPCR targets 62 MEK inhibitors 62 small molecule agonists 62 siRNA therapeutic 62 small molecule modulators 62 tkRNAi technology 62 therapeutic monoclonal antibodies 62 oral antiviral 62 prodrugs 62 histone deacetylase HDAC 62 signal transduction inhibitor 62 Anticalins R 62 adenosine A2A 62 anti fibrotic 62 Anidulafungin 62 TAFA# 62 small molecule thrombopoietin 62 siRNA sequences 62 targeted antifolate 62 myelofibrosis polycythemia vera 62 reslizumab 62 VitiGam 62 PI3K/mTOR 62 kidney urologic 62 peripherally acting 62 telomerase inhibitor 62 Myolimus 61 HepDirect R 61 nicotinic acetylcholine receptor 61 immune modulator 61 opioid receptor antagonist 61 proteasome inhibitor 61 sodium glucose transporter 61 immuno modulatory 61 vaccine GRNVAC1 61 HCV polymerase 61 histone deacetylase inhibitor 61 ESBA# 61 BiTE 61 PORxin TM 61 orally administered inhibitor 61 beta lactamases 61 Nanobodies 61 anti secretory 61 virosome 61 HepDirect prodrug 61 small molecule glucokinase 61 antitumoral 61 liposomal formulation 61 fusion enhancers 61 potently inhibit 61 PI3K/Akt pathway inhibitor 61 targeted nucleotide prodrug 61 NS#/#A protease 61 IAP inhibitor 61 nucleoside analog 61 CB1 antagonists 61 protein kinase inhibitor 61 gallium containing 61 Enzastaurin 61 OMP #M# 61 hypoxia activated prodrug 61 selective kinase inhibitor 60 myeloproliferative disorders 60 antifungal agents 60 Nanobody ® 60 PSN# [002] 60 biased ligand 60 peptide conjugated 60 Sudhir Agrawal D.Phil 60 nitric oxide donating 60 R roscovitine 60 FVIIa 60 Locked Nucleic Acid LNA 60 immune modulating 60 preclinical xenograft models 60 mGluR2 NAM 60 selective immunoproteasome inhibitor 60 vidofludimus 60 NuMimetic TM 60 antifolates 60 vascular disrupting agents 60 catalytic antioxidant compounds 60 p# inhibitor 60 Tß4 60 SGLT inhibitors 60 Akt inhibitor 60 protein kinase inhibitors 60 selective modulator 60 BCR ABL inhibitors 60 siRNA therapeutics 60 somatostatin analogue 60 oral prodrug 60 NTDDS 60 enzyme inhibitors 60 TLR8 60 Factor VIIa 60 receptor tyrosine kinase inhibitor 60 oral Janus kinase 60 investigational monoclonal antibody 60 HuCAL GOLD R 60 indibulin 60 organ transplant rejection 60 potent cytotoxic 60 tyrosine kinase inhibitor 60 selectively inhibits 60 Potelligent Technology 60 TG# [003] 60 mda 7 60 preclinically 60 PI3K inhibitors 60 Guanilib 60 PDE4 inhibitor 60 CB2 selective 60 erythropoietic 60 immunoregulation 60 Xencor XmAb 60 VEGF inhibitors 60 Aviptadil 60 bispecific antibody 60 vitamin D analogs 60 investigational humanized monoclonal antibody 60 LNP formulations 60 M1 muscarinic 60 Tarvacin TM 60 small molecule activator 60 biomarker identification 60 Aganocide ® 60 Blinatumomab 60 histone deacetylase HDAC inhibitors 60 targeted radiotherapeutic 60 JAK inhibitor 60 Azedra 60 gastrointestinal motility disorders 60 oral ghrelin agonist 60 gastro intestinal inflammation 60 immune stimulatory 60 rxRNA 60 lipid nanoparticle 60 chimeric monoclonal antibody 60 uricase 60 A3 adenosine receptor 60 preclinical compounds 60 ATL# [002] 60 NEUGENE antisense 60 Cyclosert 60 inhaled formulations 60 Pazopanib 60 angiogenesis inhibitor 60 Tissue Factor 60 Pathway Inhibitor 60 PI3 kinase inhibitors 60 dermatologic diseases 60 JAK2 enzyme 60 telomerase activators 60 IAP inhibitors 59 Anticalins 59 HuCAL antibody 59 GPR# agonists 59 CYT# potent vascular disrupting 59 EGFR HER 59 prostaglandin synthesis 59 IMC #B 59 TÎ ² 4 59 Revimmune TM 59 Curaxin 59 leukotriene pathway 59 CEQ# 59 antiangiogenesis 59 PEGylated 59 TOCOSOL 59 biobetter 59 Alfacell proprietary ribonuclease 59 tiapamil 59 Potelligent 59 mertansine 59 Deforolimus 59 pan HDAC inhibitor 59 inverse agonist 59 GSK3B 59 potent antiproliferative 59 OncoVex 59 Darinaparsin 59 kinase inhibition 59 THR beta agonist 59 selective inhibition 59 USP# 59 synthetic retinoid 59 IL# PE 59 NB S# strontium malonate 59 lipopeptide 59 tubulin inhibitor 59 delafloxacin 59 tumorigenicity 59 candidate deforolimus 59 subtype selective 59 PEGylated interferon 59 NEUGENE R 59 HGS# 59 IMiDs R 59 apoptotic pathway 59 NEUGENE 59 HTS assay 59 NP2 Enkephalin 59 non nucleoside HCV 59 Sphingomab TM 59 AtuRNAi 59 fibrotic disease 59 acadesine 59 inhibits protein synthesis 59 Lpathomab 59 AEG# 59 peptibody 59 patented Bioral 59 Aplidin R 59 Symadex 59 Pentraxin 2 59 small molecule activators 59 ATL# [001] 59 Anticalin 59 5 HT2C 59 GPR# agonist 59 SARMs 59 ErbB3 HER3 59 myeloproliferative diseases 59 DiLA2 59 immunomodulator 59 Homspera TM 59 PrevOnco 59 siRNA duplexes 59 Hsp# inhibitors 59 novel anti infective 59 flavopiridol 59 molecular biomarkers 59 deacetylase inhibitors 59 Angiolix 59 Luteinizing Hormone Releasing Hormone 59 MTP inhibitor 59 novel antiviral therapeutics 59 Dyax phage display 59 cyclophilin inhibitors 59 #ME# 59 mucoregulator 59 including eniluracil ADH 59 nucleoside analogs 59 PDE# inhibitors 59 AV HALT 59 mimetic compounds 59 JAK2 inhibitor 59 immunotherapeutics 59 proprietary phage display 59 plasma kallikrein 59 selective antagonists 59 orally dosed 59 selective antagonist 59 Spiegelmer 59 dAbs 59 cationic lipid 59 kinase inhibitor 58 VDAs 58 preclinical efficacy 58 investigational pan BCR 58 PDE7 inhibitors 58 chimeric antibody 58 PORxin 58 alpha#beta# integrin 58 stem cell mobilizer 58 ACTCellerate 58 neuronal nicotinic receptor NNR 58 EGFR antibodies 58 HSP# inhibitors 58 imatinib Gleevec ® 58 thalidomide Thalomid 58 ADCC enhanced 58 ADP receptor antagonist 58 oncogenic signaling 58 MDRNA proprietary 58 biologic therapeutics 58 ghrelin antagonist 58 KL4 surfactant 58 CDK inhibitor 58 taxane derivative 58 MEK inhibitor 58 humanized monoclonal antibody 58 Aflibercept 58 PI3K Akt 58 fosbretabulin 58 pharmacodynamic markers 58 diagnostic biomarkers 58 highly selective inhibitor 58 LHRH antagonists 58 IgG1 monoclonal antibody 58 mGluR4 58 anti CD3 58 Fc fusion protein 58 carbohydrate polymers 58 effector function 58 multitargeted 58 rxRNA ™ compounds 58 TLR9 agonist 58 targeting CD# 58 Aplidin 58 CG# [003] 58 NS5B polymerase 58 HuLuc# 58 antibody fragment 58 Pimavanserin 58 sodium stibogluconate 58 sodium thiosulfate STS 58 vascular disrupting agent 58 RNA antagonist 58 Erimos 58 glucagon receptor 58 HDL Mimetic Peptide 58 histone deacetylase 58 PSMA antibody 58 humanized anti 58 immunomodulatory 58 small molecule tyrosine 58 Vidofludimus 58 XL# XL# 58 immunoregulatory 58 biologic pathway 58 HCV protease inhibitors 58 Talabostat 58 EHT AGN 58 CCR9 antagonist 58 Morpholino 58 immunomodulatory effects 58 miRNA biomarkers 58 Cyclosporin 58 potent inhibitors 58 replicon 58 humanised monoclonal antibody 58 TLR antagonists 58 sodium glucose cotransporter 58 anti phosphatidylserine 58 cMET 58 cardiometabolic disorders 58 daptomycin 58 Posiphen TM 58 candidate CRLX# 58 leading oral taxane 58 Sym# 58 γ secretase 58 IgG1 antibody 58 vivo pharmacology 58 solithromycin 58 Cathepsin S 58 molecular imaging radiopharmaceuticals 58 RAF kinase 58 Aganocide 58 Pyridorin 58 liposome formulation 58 PNP inhibitor 58 POTELLIGENT ® 58 CD# monoclonal antibody 58 neuroprotective properties 58 anti infective treatments 58 ophthalmic diseases 58 Dapagliflozin 58 brain penetrant 58 XTEN 58 Safinamide 58 Novosom 58 OTCBB NRGX biotechnology 58 immune modulatory 58 AQ4N 58 HDACi 58 antiviral antibacterial 58 Thiovir 58 Onconase 58 cytoprotective 58 Sphingomab 58 prophylactic vaccine 58 2 methoxyestradiol 58 PPARγ 58 Annexin A5 58 MCSP respectively 58 Afatinib 58 small molecule inhibitors 58 CYT# 58 Nasdaq IDIX biopharmaceutical 58 SMARTICLES ® 58 peptide hormone 58 optical biosensors 58 androgen receptor AR 58 ddRNAi 58 muscarinic 58 Xanafide 58 orally bioavailable mimics 58 muscarinic receptor agonist 58 molecularly targeted 58 cathepsins 58 Orally administered 58 anti idiotype 58 vivo validation 58 melanocortin receptor 58 inhibit metastasis 58 glycosylation profile 58 rifamycin 58 3 kinase PI3K 58 Aptamer 58 YONDELIS R 58 novel immunotherapeutic 58 CDK inhibitors 58 drug conjugates ADCs 58 partial agonist 58 busulfan 58 adipose derived stem cell 58 peptidomimetic 58 allergic airway inflammation 58 antiviral compounds 58 non nucleoside 58 anti tubercular 58 anti amnesic 58 Apo2L 58 vivo potency 58 Annamycin 58 Adnectin 58 nucleotide analogs 58 tkRNAi 58 HuCAL R 58 LPA1 receptor 58 ALN TTR 57 PGL# 57 delta opioid receptor 57 predictive biomarkers 57 GVAX ® 57 FOLOTYN ® 57 therapeutic mAbs 57 anticancer compound 57 NPC 1C 57 NeoLipid TM 57 PI3 K 57 OHR/AVR# 57 fast skeletal troponin 57 ALK inhibitor 57 RNA antagonists 57 KL4 Surfactant 57 Curaxin CBLC# 57 telomerase inhibitor drug 57 CYT# novel 57 HDAC inhibition 57 isotypes 57 muscarinic antagonist 57 reversible inhibitor 57 Elvitegravir 57 monoclonal antibody therapeutics 57 GeneICE 57 antisense therapies 57 gastrointestinal stromal tumors GISTs 57 HDAC inhibitor 57 Radezolid 57 isoform selective 57 DermaPrep 57 Spiegelmers ® 57 murine model 57 immunological diseases 57 echinocandins 57 glucokinase activator 57 protein tyrosine phosphatase 1B 57 ophthalmology dermatology cardiovascular disease 57 oral antiplatelet agent 57 selective orally bioavailable 57 cancer immunotherapies 57 AVI NEUGENE 57 therapeutic peptide 57 phage display libraries 57 Ostabolin C TM 57 Tesetaxel 57 MKC# MKC# PP 57 prostanoid 57 Homspera ® 57 Fleximer R 57 Phylomer 57 Hemopurifier 57 thyroid hormone receptor 57 YONDELIS 57 intravesical instillation 57 5 HT4 57 cardio metabolic diseases 57 CRTH2 57 Omacetaxine 57 Liprotamase 57 small molecule 57 hPTH #-# 57 CDDO Im 57 highly selective endothelin 57 Onconova 57 5 HT3 antagonist 57 CBLC# 57 OXIGON TM 57 inhibit viral replication 57 proliferative diseases 57 liposomal 57 Spiegelmer ® 57 TPI ASM8 57 PKC# 57 renin inhibitors 57 neuropsychiatric diseases 57 ART# 57 CD# antibodies 57 ophthalmic therapeutics 57 demonstrated antitumor activity 57 TKB# 57 Lisofylline LSF 57 polymerase inhibitors 57 huC# DM4 57 tumor subtypes 57 peripherally restricted 57 NF kB Decoy 57 oral JAK1 57 radionuclide therapy 57 antagomirs 57 selectively inhibited 57 receptor inhibitor 57 auristatin 57 novel anticancer 57 PI3K inhibitor 57 novel antibody therapeutics 57 mTOR inhibitors 57 resolvins 57 cynomolgus monkeys 57 selective adenosine 57 Micromet BiTE 57 mitochondrial toxicity 57 Pancreate 57 protein mTOR 57 oncolytic 57 aurora kinase inhibitor 57 Affimed Therapeutics AG 57 tubulin binding 57 proprietary PEGylation 57 Carfilzomib 57 estrogen receptor beta 57 TRAIL receptor antibodies 57 sulfonylhydrazine class 57 targeting PCSK9 57 hemorrhagic fever viruses 57 ProLindac TM 57 androgen receptor antagonist 57 Chemokine Receptor 57 alpha#beta# 57 affinity ligands 57 thrombin receptor 57 NMDA antagonists 57 thapsigargin 57 PEG SN# 57 Ganetespib 57 chronic viral infections 57 radezolid 57 chlamydial 57 Vidaza azacitidine 57 neuronal nicotinic receptors NNRs 57 RNAi therapeutic targeting 57 GRN#L 57 neuroactive 57 P#X# antagonist 57 aurora kinase 57 nanomedicines 57 antiangiogenic 57 tumor xenograft models 57 rhIGF-I/rhIGFBP-3 57 intracellular signaling pathways 57 ANTISENILIN ® 57 BAL# [001] 57 pathophysiological effects 57 MAbs targeting 57 ATL/TV# 57 nanoviricides 57 MAb 57 hypoxia inducible factor 57 synthetic siRNA 57 #HT#A 57 BRAF kinase 57 recombinant antibodies 57 rifalazil 57 enzyme inhibitor 57 neuro protective 57 Seliciclib 57 non nucleoside inhibitor 57 factor TNF 57 novel immunotherapies 57 Chipscreen 57 proliferative disorders 57 AFREZZA TM 57 ophthalmology oncology 57 oncolytic viruses 57 novel VDA molecule 57 Stapled Peptide 57 Anavex #-# 57 Darapladib 57 short hairpin RNAs 57 mu opioid receptor antagonist 57 CTLA4 Ig 57 novel orally bioavailable 57 sd rxRNA compounds 57 selective agonists 57 G Protein Coupled 57 Nanobodies ® 57 chemical entities NCEs 57 HepeX B TM 57 Aurora kinase 57 GelSite R polymer 57 ALK inhibitors 57 HCV protease inhibitor 57 Tofacitinib 57 proprietary biomaterials 57 AT1R 57 anticoagulant reversing agent 57 humanized antibodies 57 angiotensin analog 57 GRNVAC1 57 HepDirect 57 Teriflunomide 57 MKC# MT 57 Phase #b/#a clinical 57 NXL# 57 HQK 57 CD# antibody [001] 57 mTOR mammalian target 57 gamma secretase inhibitors 57 Camptothecin 57 XmAb 57 cathepsin K inhibitor 57 bispecific 57 DNA intercalator 57 pathogenic mechanisms 57 Endotis 56 Nektar proprietary 56 BRAF inhibitor 56 nicotinic receptor 56 Monoclonal antibody 56 mTOR inhibition 56 Pseudomonas aeruginosa infections 56 Gleevec resistant 56 TTR amyloidosis 56 triterpenoids 56 nanoparticle formulation 56 Hsp# inhibition 56 systemic siRNA 56 IMiDs ® 56 dSLIM 56 insulin sensitizer 56 chemically modified siRNA 56 Schisandrin B 56 BHT DNA 56 hypereosinophilic syndrome 56 systemic RNAi therapeutic 56 phosphoprotein 56 nucleotide analog 56 Viprovex TM 56 RTP #i 56 rBChE 56 Panzem R 56 EP #R 56 Virdante 56 RECOTHROM R 56 SuperAntibody 56 oral leukoplakia 56 interferon lambda 56 Exelixis compounds 56 SinuNase ™ 56 TLR9 agonists 56 EGFR HER2 56 Phase IIb clinical trials 56 MAGE A3 ASCI 56 anti angiogenic agents 56 TRV# [001] 56 MGd 56 synthetic cannabinoid compounds 56 telomerase therapeutic 56 XmAb ® 56 C5aR 56 Anticalin R 56 POTELLIGENT R 56 essential thrombocythemia ET 56 macrocyclic 56 ketolide antibiotic 56 Zalypsis 56 dasatinib Sprycel 56 phosphate S1P 56 cilengitide 56 integrative pharmacology 56 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 56 MP4 molecule 56 peroxisome proliferator activated 56 Oral NKTR 56 peptidic 56 CCR5 antagonist 56 allogeneic cell 56 histone deacetylase inhibitors 56 Zolinza 56 CB2 selective receptor agonist 56 DOS# 56 antifibrotic 56 integrin receptors 56 Glypromate 56 CB2 receptor selective 56 small molecule defensin 56 novel therapeutic antibodies 56 anticancer compounds 56 irinotecan oxaliplatin 56 fibrotic diseases 56 ARIKACE ™ 56 Solazed TM 56 splice variants 56 oxazolidinone 56 platinum chemotherapeutic 56 mimetics 56 Kinase Inhibitor 56 NS5b 56 P#X# 56 PTP 1B 56 selectively inhibiting 56 wilate ® 56 agent VDA 56 Mutation Analysis 56 Capsulution 56 FGFR 56 serine proteases 56 topical anti infectives 56 CobaCyte 56 adenoviral 56 IKK epsilon 56 murine antibodies 56 cellular pathways 56 Cancidas 56 ghrelin agonist 56 gefitinib Iressa 56 TLR8 agonist 56 beta adrenergic 56 DNA methylation biomarkers 56 Calando proprietary 56 Wnt signaling pathway 56 small molecule chemotherapeutic 56 intranasal formulation 56 mesenchymal stromal cells 56 MorphoSys proprietary 56 diarrhea predominant irritable 56 chemopreventive agent 56 acyclovir Lauriad R 56 Homspera 56 phage display 56 DACH platinum 56 SUTENT ® 56 NF kB pathway 56 protein tyrosine phosphatases 56 vapreotide acetate 56 chemokine receptors 56 JAK1 56 immunomodulating 56 transfection reagents 56 MAPK pathway 56 siRNA compounds 56 fatty acid biosynthesis 56 antibacterial therapeutics 56 quinoline 56 selective kinase inhibitors 56 Monoclonal 56 CCR1 56 anti angiogenic drugs 56 fatty acid amide hydrolase 56 prognostic biomarker 56 Tr DNA 56 inhaled formulation 56 GABAA receptor 56 Janus kinase 56 TRX1 56 GelSite polymer 56 Liposomal 56 Maxy G# 56 Presents Preclinical Data 56 tumor vascular disrupting 56 accumulate preferentially 56 orally bioavailable 56 NovaBay Aganocide compounds 56 oral JAK#/JAK# inhibitor 56 Epidermal Growth Factor Receptor 56 liposomal delivery 56 Anti Phospholipid Therapy 56 mitotic kinesin 56 HSP# inhibitor 56 p# inhibitors 56 Clusterin 56 biologic pathways 56 p# mitogen activated 56 PPARgamma 56 topical anti infective 56 Affibody ® molecules 56 LEAPS TM 56 Fenretinide 56 neuroprotective agent 56 Geron telomerase inhibitor 56 TRPV1 agonist 56 mineralocorticoid 56 recombinant biopharmaceutical 56 intracellular protein 56 anti CD# antibodies 56 vivo preclinical 56 miRNA molecules 56 AAG geldanamycin analog 56 Celator 56 Selective Electrochemical Tumor Ablation 56 selective androgen receptor modulator 56 proprietary polysaccharide 56 SYN# 56 Curaxins 56 alkylating agent 56 anionic backbone 56 metastatic neuroendocrine tumors 56 SGLT2 inhibitors 56 ganaxolone 56 engineered proteases 56 monoclonal 56 Systemic lupus erythematosus SLE 56 recombinant polyclonal antibodies 56 cyclin dependent kinase inhibitor 56 multicenter Phase II 56 polyclonal antibodies 56 antidiabetic 56 dacetuzumab 56 molecular assays 56 Atiprimod 56 ABL inhibitor 56 BrachySil TM 56 acetylcholinesterase 56 adrenoceptor 56 adipogenic 56 PROfusion 56 ospemifene 56 HDL Selective Delipidation 56 nucleoside analogues 56 kinase profiling 56 NS3 protease 56 phosphoinositide 3 56 heterocyclic 56 generation antisense 56 GMX# 56 XmAb TM 56 MolecularBreeding 56 SIRT1 enzyme 56 Alvine Pharmaceuticals 56 clinically validated targets 56 fluconazole resistant 56 neuroprotectant 56 NNR Therapeutics 56 polymerase inhibitor 56 XP# XP# 56 investigational compounds 56 novel prodrug 56 Sertoli cell 56 Azacitidine 56 polyclonal antibody 56 Archexin 56 geldanamycin 56 G#DT 56 ON #.Na 56 Photodynamic therapy PDT 56 phage display technology 56 HuCNS SC ® 56 ZFP Therapeutics 56 pharmacologic approaches 56 proteins peptides 56 immunomodulatory properties 56 potent inducer 56 acetonide FA 56 novel topoisomerase 56 AtuPLEX 56 GERD migraine headaches 56 proteasome inhibition 56 neuraminidase inhibitor 56 Pentad TM 56 protein misfolding diseases 56 ALN TTR# 56 small molecule inhibitor 56 2DG 56 Quark Biotech Inc. 56 IGF IR 56 microtubule targeting 56 pharmacological chaperone 56 induce apoptosis 56 Alequel 56 Spiegelmers 56 diagnostic biomarker 55 biochemical assays 55 topical formulations 55 kinase PI3K 55 SERMs 55 PSMA ADC 55 visilizumab 55 HTRF 55 antiangiogenesis therapies 55 mRNA antagonist 55 Smac mimetics 55 vinca alkaloid 55 mediated inhibition 55 OXi# 55 investigational therapies 55 oral immunomodulatory 55 Dalbavancin 55 subcutaneous formulation 55 AIR# [001] 55 5 HT2A receptor 55 Bevirimat 55 adipiplon 55 macrocycles 55 epothilone 55 cytochrome P# inhibition 55 allosteric modulator 55 camptothecin 55 immune modulation 55 prostone 55 Adenosine Therapeutics 55 PDE4 55 lymphoid tumors 55 Trofex 55 anti CD3 monoclonal 55 XL# anticancer compounds 55 Aurora Kinase 55 BioSilicon 55 favorable pharmacokinetic profile 55 NSCLC tumors 55 hepatoma 55 calcitonin gene related 55 c myb 55 tRNA synthetase 55 antisense drug 55 Mipomersen 55 EnVivo 55 antineoplastic 55 signaling cascades 55 Cetrorelix 55 novel orally administered 55 Th2 cytokines 55 Lenocta 55 bifunctional 55 TELINTRA 55 novel antifolate 55 Initiates Enrollment 55 receptor antagonists 55 Enhanze Technology 55 Cloretazine 55 gamma secretase inhibitor 55 virus AAV 55 BGC# 55 peptide ligands 55 p# alpha [001] 55 alagebrium 55 prostaglandin D2 55 antibacterial antiviral 55 Reports Preclinical Data 55 Protein Kinase C 55 HCV polymerase inhibitor 55 DermaVir Patch 55 tumor hypoxia 55 activate SIRT1 55 immunotherapeutic 55 ANTISENILIN R 55 antiangiogenic agent 55 engineered RAP peptides 55 isotype 55 dopamine D1 55 Anticalins ® 55 interleukin IL -# 55 protein tyrosine 55 monoclonal antibodies MAbs 55 PRT#